Barclays Increases BioCryst Pharmaceuticals (NASDAQ:BCRX) Price Target to $11.00
BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) had its target price hoisted by Barclays from $8.00 to $11.00 in a research report report published on Wednesday morning,Benzinga reports. Barclays currently has an equal weight rating on the biotechnology company’s stock. Several other research analysts have also recently issued reports on the stock. StockNews.com raised shares of […]
BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) had its target price hoisted by Barclays from $8.00 to $11.00 in a research report report published on Wednesday morning,Benzinga reports. Barclays currently has an equal weight rating on the biotechnology company’s stock. Several other research analysts have also recently issued reports on the stock. StockNews.com raised shares of […]
